Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o
Go back to Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 108.40 +0.80 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.60 | 52 Week High | $39.41 | |||
| Open | $108.95 | 52 Week Low | $25.98 | |||
| Day High | $110.45 | P/E | 152.68 | |||
| Day Low | $107.60 | EPS | $0.71 | |||
| Volume | 1,300,442 | |||||
